Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.

Brys I, Nunes J, Fuentes R.

Eur J Neurosci · 2017-04-22

DOI: 10.1111/ejn.13568PMID: 28370471

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.

Yang L, Stewart T, Shi M, Pottiez G, Dator R, Wu R, Aro P, Schuster RJ, Ginghina C, Pan C, Gao Y, Qian W, Zabetian CP, Hu SC, Quinn JF, Zhang J.

Proteomics Clin Appl · 2017-04-19

DOI: 10.1002/prca.201700045PMID: 28319654

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.

Rocha EM, De Miranda B, Sanders LH.

Neurobiol Dis · 2017-04-08

DOI: 10.1016/j.nbd.2017.04.004PMID: 28400134

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca-Ornelas L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, Fauvet B, Penque D, Pais TF, Tong Q, Becker S, Kügler S, Lashuel HA, Steegborn C, Zweckstetter M, Outeiro TF.

PLoS Biol · 2017-04-05

DOI: 10.1371/journal.pbio.1002601PMID: 28379951

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca-Ornelas L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, Fauvet B, Penque D, Pais TF, Tong Q, Becker S, Kügler S, Lashuel HA, Steegborn C, Zweckstetter M, Outeiro TF.

PLoS Biol · 2017-03-03

DOI: 10.1371/journal.pbio.2000374PMID: 28257421

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.

Acta Neuropathol · 2017-02-08

DOI: 10.1007/s00401-017-1684-zPMID: 28180961

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Lingor P, Carboni E, Koch JC.

J Neural Transm (Vienna) · 2017-02-06

DOI: 10.1007/s00702-017-1695-xPMID: 28168622

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T.

Acta Neuropathol Commun · 2017-01-05

DOI: 10.1186/s40478-016-0408-2PMID: 28057070

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.

Mo M, Xiao Y, Huang S, Cen L, Chen X, Zhang L, Luo Q, Li S, Yang X, Lin X, Xu P.

Oncotarget · 2017-01-01

DOI: 10.18632/oncotarget.13905PMID: 27965467

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.

Niu S, Zhang LK, Zhang L, Zhuang S, Zhan X, Chen WY, Du S, Yin L, You R, Li CH, Guan YQ.

Theranostics · 2017-01-01

DOI: 10.7150/thno.16562PMID: 28042339

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene.

Nussbaum RL.

J Parkinsons Dis · 2017-01-01

DOI: 10.3233/jpd-179003PMID: 28282812

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease.

Gibbons CH, Wang N, Freeman R.

J Parkinsons Dis · 2017-01-01

DOI: 10.3233/jpd-171088PMID: 28582870

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

715 makale bulundu

Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.

Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene.

Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease.

Filtreler